The UK's key to becoming a life science superpower

7 March 2023

An Expert View from Giles Campion, head of R&D and chief medical officer, Silence Therapeutics.

The UK has a world-leading life sciences sector based on top discovery research, a world-class regulatory agency, and access to private capital. Our network of thriving companies and leading academic institutions has a long heritage of working together on everything from foundational scientific research to later-stage commercial clinical trials.

The scientific breakthroughs the UK has made in new therapeutics, especially in relatively new fields such as oligonucleotides, biopharmaceuticals and advanced therapeutic medicinal products (ATMPs), highlight the nation’s potential to become a hub for the development of novel therapies and a global superpower in the life sciences.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK